Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
162.2 INR | +2.24% | +2.01% | +1.02% |
04-18 | Marksans Pharma's Goa Facility Gets Five Inspectional Observations from US FDA | MT |
02-14 | Transcript : Marksans Pharma Limited, Q3 2024 Earnings Call, Feb 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+1.02% | 861M | |
+31.06% | 688B | |
+30.35% | 588B | |
-3.42% | 364B | |
+18.02% | 326B | |
+4.27% | 285B | |
+15.53% | 239B | |
+10.16% | 210B | |
-8.14% | 200B | |
+8.12% | 167B |
- Stock Market
- Equities
- MARKSANS Stock
- News Marksans Pharma Limited
- Marksans Pharma Completes Acquisition of Manufacturing Site in Goa, India